SynthesisCNS drugs2021

Comparative Efficacy and Safety of Ozanimod and Dimethyl Fumarate for Relapsing-Remitting Multiple Sclerosis Using Matching-Adjusted Indirect Comparison.

Stanley Cohan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.